Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMAL DP dosing for malaria preventive treatment in Malawian infants
PACTR202211575727659Phase 3Not yet recruiting
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dihydroartemisinin + piperaquine in malaria (2 arms), sponsored by Liverpool School of Tropical Medicine. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202211575727659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202211575727659.